RNA interference in dermal and fibrotic indications

Details for Australian Patent Application No. 2011232365 (hide)

Owner RXi Pharmaceuticals Corporation

Inventors Khvorova, Anastasia; Salomon, William; Kamens, Joanne; Samarsky, Dmitry; Woolf, Tod M.; Pavco, Pamela A.; Libertine, Lyn; Cardia, James

Agent Pizzeys

Pub. Number AU-A-2011232365

PCT Pub. Number WO2011/119887

Priority 61/317,252 24.03.10 US; 61/317,633 25.03.10 US

Filing date 24 March 2011

Wipo publication date 29 September 2011

International Classifications

A61K 31/713 - Double-stranded nucleic acids or oligonucleotides

C07H 21/02 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

25 October 2012 PCT application entered the National Phase

  PCT publication WO2011/119887 Priority application(s): WO2011/119887

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011232374-Preparation of regenerative tissue scaffolds

2011232362-System and methods for treating a bifurcation